As larger competitors responded via practitioner marketing programs, radiation oncology company Accuray needed a new strategy to maintain its strong growth rates. We recommended and executed a co-operative Direct-to-Patient Campaign to create ongoing demand for Accuray’s Cyberknife solution. The result: Our work for Cyberknife helped drive 20:1 ROI, 75% growth, and a successful IPO for Accuray.